BioMarin Pharmaceutical Inc. (BMRN)
-NasdaqGS 58.31 
0.14(0.24%) 4:00PM EDT|After Hours
:
58.31 0.00 (0.00%) 4:29PM EDT
| Prev Close: | 58.17 |
|---|
| Open: | 58.00 |
|---|
| Bid: | 57.21 x 200 |
|---|
| Ask: | 58.85 x 200 |
|---|
| 1y Target Est: | 70.70 |
|---|
| Beta: | 0.54 |
|---|
| Next Earnings Date: | 29-Jul-13 |
|---|
| Day's Range: | 57.21 - 58.78 |
|---|
| 52wk Range: | 35.99 - 71.56 |
|---|
| Volume: | 835,824 |
|---|
| Avg Vol (3m): | 1,443,420 |
|---|
| Market Cap: | 8.11B |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -1.05 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Highlights from the Goldman Sachs Healthcare Conferenceat Motley Fool(Tue 12:20PM EDT)
- Niche drugmaker ViroPharma attracts takeover interest -sourcesat Reuters(Mon, Jun 17)
- Orphan drugmaker ViroPharma attracts takeover interest: sourcesat Reuters(Mon, Jun 17)
- Orphan drugmaker ViroPharma attracts takeover interest -sourcesat Reuters(Mon, Jun 17)
- BioMarin Pharmaceutical Inc. Presents at Goldman Sachs 34th Annual Global Healthcare Conference, Jun-13-2013 10:00 AMat Seeking Alpha(Thu, Jun 13)
- The Best Kind of Biotech Dilutionat Motley Fool(Wed, Jun 12)
- Biomarin Pharmaceutical Inc. (BMRN): Today's Featured Health Care Winnerat TheStreet(Tue, Jun 11)
- UPDATE: Jean-Jacques Bienaime, CEO of BioMarin, to Present at the Goldman Sachs Global Healthcare ConferenceGlobeNewswire(Thu, Jun 6)
- BioMarin to Present at the Goldman Sachs Global Healthcare ConferenceGlobeNewswire(Thu, Jun 6)
- Post-ASCO Movers: Are Any a Buy?at Motley Fool(Wed, Jun 5)
- BioMarin Initiates Phase 3 Trial for PEG-PAL for the Treatment of PKUGlobeNewswire(Wed, Jun 5)
- After the close: Biogen slips, Epizyme slows, BioMarin stallsat MarketWatch(Tue, Jun 4)
- Analysts: Buy Buffalo Wild Wings In the Low $90s and 3 More Research Notes to Check Outat Wall St. Cheat Sheet(Tue, Jun 4)
- Will Arena Pharmaceuticals See Rising Prices?at Wall St. Cheat Sheet(Tue, Jun 4)
- Cramer Says Buy Barnes & Noble, Buy Under Armour, Buy BioMarinat Wall St. Cheat Sheet(Tue, Jun 4)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 15.79 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -1.32 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.29 |
|---|
| Mean Recommendation*: | 1.8 |
|---|
| PEG Ratio (5 yr expected): | -1.30 |
|---|
Business Summary
BioMarin Pharmaceutical Inc. develops and commercializes biopharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and internationally.
View More